Triple-hormone receptor agonist retatrutide significantly improves lipoprotein and apolipoprotein profiles in participants with obesity or overweight
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Monash University, Melbourne (Australia)
3 More presentations in this session
Professor M. Sabatine (Boston, US)
Clinical outcomes according to residual cholesterol and inflammatory risk in patients undergoing PCI
Doctor B. Bay (Hamburg, DE)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
